Cargando...

Adjuvant treatment with thyrotropin alpha for remnant ablation in thyroid cancer

Various studies have demonstrated the safety and efficacy of recombinant human thyroid-stimulating hormone (rhTSH) for radioiodine remnant ablation. On this basis, rhTSH was approved in Europe for the radioiodine ablation of low-risk differentiated thyroid cancer (DTC) during thyroid hormone therapy...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Biondi, Bernadette, Pulcrano, Melania, Pagano, Loredana, Lombardi, Gaetano
Formato: Artigo
Idioma:Inglês
Publicado: Dove Medical Press 2009
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2726080/
https://ncbi.nlm.nih.gov/pubmed/19707391
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!